Nvidia and Roche Group’s Genentech have announced a multi-year strategic collaboration to advance AI research in drug discovery and expedite the delivery of novel therapies to patients. Through this partnership, Genentech will combine its own models and datasets with Nvidia’s AI computing stack to leverage generative AI. Nvidia’s DGX Cloud and BioNemo offerings will play a key role in this collaboration.
Nvidia Collaborates with Genentech to Pioneer the Use of Generative AI in Drug Discovery
